CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- S-1/A Offering Registration Statement
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 4 Insider Changes in Ownership
- 8-K Event Bylaws or fiscal year change
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 8-K Event Executive or director change · Shareholder vote results · Other events
- S-1/A Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Agreement ended · Unregistered share sale · Shareholder rights changed · Other events
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Shareholder rights changed · Other events
Page 29 of 74 · 1,467 filings